Approvals/TGA/L.C.E. SANDOZ 125/31.25/200 levodopa 125 mg, carbidopa (as carbidopa monohydrate) 31.25 mg and entacapone 200 mg film-coated tablet bottle

Approved

STANDARD

L.C.E. SANDOZ 125/31.25/200 levodopa 125 mg, carbidopa (as carbidopa monohydrate) 31.25 mg and entacapone 200 mg film-coated tablet bottle

Sandoz Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 28, 2025
Approval ID: d3f875c75a17bb3c
Company: Sandoz Pty Ltd
Type: Standard

Approval Details

Approval Id: d3f875c75a17bb3c
Product Name: L.C.E. SANDOZ 125/31.25/200 levodopa 125 mg, carbidopa (as carbidopa monohydrate) 31.25 mg and entacapone 200 mg film-coated tablet bottle
Artg Id: 192175
Artg Name: L.C.E. SANDOZ 125/31.25/200 levodopa 125 mg, carbidopa (as carbidopa monohydrate) 31.25 mg and entacapone 200 mg film-coated tablet bottle
Sponsor: Sandoz Pty Ltd
Company Detail Path: /organization/sandoz-pty-ltd
Artg Date: 2013-11-14
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/451e8114498b45e55445a9d112650247.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6829e420e438b72a61dca95710b56830.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 28, 2025

Approval ID

d3f875c75a17bb3c

Type

Standard

Back to TGA Approvals